MANAGEMENT AND COST ANALYSIS OF CANCER PATIENTS TREATED WITH G-CSF: A COHORT STUDY BASED ON THE FRENCH NATIONAL HEALTHCARE INSURANCE DATABASE (ECHANTILLON GENERALISTE DES BENEFICIAIRES)

被引:0
|
作者
Tilleul, P. [1 ]
Jacot, W. [2 ]
Emery, C. [3 ]
Lafuma, A. [4 ]
Gourmelen [5 ]
Fabre, N. [6 ]
Gaudin, H. [6 ]
机构
[1] Nantes Hosp Univ, Nantes, France
[2] Inst Reg Canc Montpellier, Montpellier, France
[3] Cemka, Bourg La Reine, France
[4] Cemka Eval, Bourg La Reine, France
[5] UVSQ, INSERM, UMS 011, Villejuif, France
[6] Chugai Pharma France, Puteaux La Defense, France
关键词
D O I
10.1016/j.jval.2017.08.365
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN282
引用
收藏
页码:A463 / A463
页数:1
相关论文
共 31 条
  • [1] Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database
    Tilleul, Patrick
    Jacot, William
    Emery, Corinne
    Lafuma, Antoine
    Gourmelen, Julie
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (12) : 1261 - 1267
  • [2] Insulin glargine and risk of cancer: a cohort study in the french national healthcare insurance database
    Blin, P.
    Lassalle, R.
    Dureau, C.
    Ambrosino, B.
    Bernard, M. A.
    Abouelfath, A.
    Gin, H.
    Le Jeunne, C.
    Pariente, A.
    Droz, C.
    Moore, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 76 - 77
  • [3] Insulin Glargine and Risk of Cancer: A Cohort Study in the French National Healthcare Insurance Database
    Blin, Patrick
    Lassalle, Regis
    Dureau, Caroline
    Ambrosino, Basmah
    Bernard, Marie-Agnes
    Abouelfath, Abdelilah
    Gin, Henri
    Le Jeunne, Claire
    Pariente, Antoine
    Droz-Perroteau, Cecile
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 8 - 8
  • [4] Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
    P. Blin
    R. Lassalle
    C. Dureau-Pournin
    B. Ambrosino
    M. A. Bernard
    A. Abouelfath
    H. Gin
    C. Le Jeunne
    A. Pariente
    C. Droz
    N. Moore
    Diabetologia, 2012, 55 : 644 - 653
  • [5] Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
    Blin, P.
    Lassalle, R.
    Dureau-Pournin, C.
    Ambrosino, B.
    Bernard, M. A.
    Abouelfath, A.
    Gin, H.
    Le Jeunne, C.
    Pariente, A.
    Droz, C.
    Moore, N.
    DIABETOLOGIA, 2012, 55 (03) : 644 - 653
  • [6] Insulin Glargine and Risk of Death or Cancer: A Cohort Study in the French National Healthcare Insurance Database
    Blin, P.
    Lassalle, R.
    Dureau, C.
    Ambrosino, B.
    Bernard, M. -A.
    Abouelfath, A.
    Gin, H.
    Le Jeunne, C.
    Pariente, A.
    Droz, C.
    Moore, N.
    DRUG SAFETY, 2012, 35 (10) : 947 - 947
  • [7] Effectiveness and cost of contraception in France (FACET study): a cohort study from the French National Healthcare Insurance Database
    Agostinia, Aubert
    Godard, Chloe
    Laurendeau, Caroline
    Benmahmoud, Amel
    Lafuma, Antoine
    Doe, Marianne
    Levy-Bachelot, Laurie
    Gourmelen, Julie
    Linete, Teddy
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 229 : 137 - 143
  • [8] Heart failure epidemiology, management and prognosis in over 80 years old patients: A cohort study in the French national healthcare insurance database
    Vorilhon, C.
    Chouki, C.
    Mulliez, A.
    Eschalier, A.
    Motreff, P.
    Lusson, J. R.
    Eschalier, R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 673 - 673
  • [9] Profile consumption of opioid maintained treatments: a national cohort study of 1074 patients from French national healthcare insurance database
    Chenaf, C.
    Delorme, J.
    Fournier-Choma, C.
    Teilhol, G.
    Eschalier, A.
    Authier, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 22 - 22
  • [10] Return to work trajectories after early breast cancer diagnosis: A population-based cohort study in the French National Healthcare Insurance database
    Varnier, R.
    Moskal, A.
    Dima, A. L.
    Bodelet, C.
    Peron, J.
    Lamort-Bouche, M.
    Fassier, J. -B.
    Viprey, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1282 - S1282